CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 846 of 865
Non-Antibody Products
Page 846 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| VU0469650 (hydrochloride) | A negative allosteric mGluR1 modulator; inhibits glutamate-induced calcium… | 10 mg | 32933-10 | More Info |
| VU0469650 (hydrochloride) | A negative allosteric mGluR1 modulator; inhibits glutamate-induced calcium… | 5 mg | 32933-5 | More Info |
| VU590 (hydrochloride) | A small molecule inhibitor of KCNJ1 (IC50 = 294 nM) which also causes 70%… | 10 mg | 15177-10 | More Info |
| VU590 (hydrochloride) | A small molecule inhibitor of KCNJ1 (IC50 = 294 nM) which also causes 70%… | 25 mg | 15177-25 | More Info |
| VU590 (hydrochloride) | A small molecule inhibitor of KCNJ1 (IC50 = 294 nM) which also causes 70%… | 5 mg | 15177-5 | More Info |
| VU6036720 (hydrochloride) | An inhibitor of heteromeric Kir4.1 / 5.1 channels (IC50 = 0.24 µM);… | 1 mg | 40286-1 | More Info |
| VU6036720 (hydrochloride) | An inhibitor of heteromeric Kir4.1 / 5.1 channels (IC50 = 0.24 µM);… | 10 mg | 40286-10 | More Info |
| VU6036720 (hydrochloride) | An inhibitor of heteromeric Kir4.1 / 5.1 channels (IC50 = 0.24 µM);… | 5 mg | 40286-5 | More Info |
| Vulpinic Acid | A lichen metabolite with diverse biological activities; active against var… | 10 mg | 21685-10 | More Info |
| Vulpinic Acid | A lichen metabolite with diverse biological activities; active against var… | 100 mg | 21685-100 | More Info |
| Vulpinic Acid | A lichen metabolite with diverse biological activities; active against var… | 25 mg | 21685-25 | More Info |
| Vulpinic Acid | A lichen metabolite with diverse biological activities; active against var… | 50 mg | 21685-50 | More Info |
| VU0155041 (sodium salt) | A selective positive allosteric modulator of mGluR4 (EC50 = 2.5 µM i… | 10 mg | 21775-10 | More Info |
| VU0155041 (sodium salt) | A selective positive allosteric modulator of mGluR4 (EC50 = 2.5 µM i… | 5 mg | 21775-5 | More Info |
| VU0155041 (sodium salt) | A selective positive allosteric modulator of mGluR4 (EC50 = 2.5 µM i… | 50 mg | 21775-50 | More Info |
| VU0364572 (trifluoroacetate salt) | A potent and selective agonist of M1 receptors (EC50 = 0.2 mM compared to… | 1 mg | 20466-1 | More Info |
| VU0364572 (trifluoroacetate salt) | A potent and selective agonist of M1 receptors (EC50 = 0.2 mM compared to… | 10 mg | 20466-10 | More Info |
| VU0364572 (trifluoroacetate salt) | A potent and selective agonist of M1 receptors (EC50 = 0.2 mM compared to… | 25 mg | 20466-25 | More Info |
| VU0364572 (trifluoroacetate salt) | A potent and selective agonist of M1 receptors (EC50 = 0.2 mM compared to… | 5 mg | 20466-5 | More Info |
| VV116 | An antiviral agent and a derivative of remdesivir; inhibits viral replicat… | 1 mg | 37745-1 | More Info |
| VV116 | An antiviral agent and a derivative of remdesivir; inhibits viral replicat… | 10 mg | 37745-10 | More Info |
| VV116 | An antiviral agent and a derivative of remdesivir; inhibits viral replicat… | 25 mg | 37745-25 | More Info |
| VV116 | An antiviral agent and a derivative of remdesivir; inhibits viral replicat… | 5 mg | 37745-5 | More Info |
| VX-509 | A selective JAK3 inhibitor (Ki = 2.5 nM; IC50 = 50-170 nM); reduces proinf… | 1 mg | 19513-1 | More Info |
| VX-509 | A selective JAK3 inhibitor (Ki = 2.5 nM; IC50 = 50-170 nM); reduces proinf… | 10 mg | 19513-10 | More Info |
| VX-509 | A selective JAK3 inhibitor (Ki = 2.5 nM; IC50 = 50-170 nM); reduces proinf… | 25 mg | 19513-25 | More Info |
| VX-509 | A selective JAK3 inhibitor (Ki = 2.5 nM; IC50 = 50-170 nM); reduces proinf… | 5 mg | 19513-5 | More Info |
| VX-661 | An investigational compound that promotes the maturation of Delta F508 mut… | 10 mg | 21480-10 | More Info |
| VX-661 | An investigational compound that promotes the maturation of Delta F508 mut… | 25 mg | 21480-25 | More Info |
| VX-661 | An investigational compound that promotes the maturation of Delta F508 mut… | 5 mg | 21480-5 | More Info |
| VX-661 | An investigational compound that promotes the maturation of Delta F508 mut… | 50 mg | 21480-50 | More Info |
| VX-702 | A third generation inhibitor of p38 MAP kinases, binding to both p38&alpha… | 10 mg | 13108-10 | More Info |
| VX-702 | A third generation inhibitor of p38 MAP kinases, binding to both p38&alpha… | 25 mg | 13108-25 | More Info |
| VX-702 | A third generation inhibitor of p38 MAP kinases, binding to both p38&alpha… | 5 mg | 13108-5 | More Info |
| VX-745 | A p38α MAPK inhibitor (IC50 = 9 nM); selective for p38α over p… | 1 mg | 18075-1 | More Info |
| VX-745 | A p38α MAPK inhibitor (IC50 = 9 nM); selective for p38α over p… | 10 mg | 18075-10 | More Info |
| VX-745 | A p38α MAPK inhibitor (IC50 = 9 nM); selective for p38α over p… | 5 mg | 18075-5 | More Info |
| VX-745 | A p38α MAPK inhibitor (IC50 = 9 nM); selective for p38α over p… | 50 mg | 18075-50 | More Info |
| VX-765 | A prodrug form of VRT-043198; inhibits LPS-induced increases in serum IL-1… | 10 mg | 28825-10 | More Info |
| VX-765 | A prodrug form of VRT-043198; inhibits LPS-induced increases in serum IL-1… | 25 mg | 28825-25 | More Info |
| VX-765 | A prodrug form of VRT-043198; inhibits LPS-induced increases in serum IL-1… | 5 mg | 28825-5 | More Info |
| VX-765 | A prodrug form of VRT-043198; inhibits LPS-induced increases in serum IL-1… | 50 mg | 28825-50 | More Info |
| VX-809 | A F508del-CFTR corrector; enhances F508del-CFTR protein maturation and res… | 1 mg | 22196-1 | More Info |
| VX-809 | A F508del-CFTR corrector; enhances F508del-CFTR protein maturation and res… | 10 mg | 22196-10 | More Info |
| VX-809 | A F508del-CFTR corrector; enhances F508del-CFTR protein maturation and res… | 25 mg | 22196-25 | More Info |
| VX-809 | A F508del-CFTR corrector; enhances F508del-CFTR protein maturation and res… | 5 mg | 22196-5 | More Info |
| W123 | An analog of FTY720 that is a competitive antagonist of S1P1; has a Ki val… | 1 mg | 10010992-1 | More Info |
| W123 | An analog of FTY720 that is a competitive antagonist of S1P1; has a Ki val… | 10 mg | 10010992-10 | More Info |
| W123 | An analog of FTY720 that is a competitive antagonist of S1P1; has a Ki val… | 5 mg | 10010992-5 | More Info |
| W-54011 | A selective C5aR antagonist (Ki = 2.2 nM); inhibitor of C5a-mediated Ca2+… | 1 mg | 21231-1 | More Info |
| W-54011 | A selective C5aR antagonist (Ki = 2.2 nM); inhibitor of C5a-mediated Ca2+… | 10 mg | 21231-10 | More Info |
| W-54011 | A selective C5aR antagonist (Ki = 2.2 nM); inhibitor of C5a-mediated Ca2+… | 25 mg | 21231-25 | More Info |
| W-54011 | A selective C5aR antagonist (Ki = 2.2 nM); inhibitor of C5a-mediated Ca2+… | 5 mg | 21231-5 | More Info |
| Walrycin B | An antibiotic that has activity against Gram-positive bacteria via inhibit… | 1 mg | 21566-1 | More Info |
| Walrycin B | An antibiotic that has activity against Gram-positive bacteria via inhibit… | 10 mg | 21566-10 | More Info |
| Walrycin B | An antibiotic that has activity against Gram-positive bacteria via inhibit… | 25 mg | 21566-25 | More Info |
| Walrycin B | An antibiotic that has activity against Gram-positive bacteria via inhibit… | 5 mg | 21566-5 | More Info |
| (-)-Warfarin | An anticoagulant; interferes with interconversion of vitamin K and vitamin… | 1 mg | 13531-1 | More Info |
| (-)-Warfarin | An anticoagulant; interferes with interconversion of vitamin K and vitamin… | 10 mg | 13531-10 | More Info |
| (-)-Warfarin | An anticoagulant; interferes with interconversion of vitamin K and vitamin… | 25 mg | 13531-25 | More Info |
| (-)-Warfarin | An anticoagulant; interferes with interconversion of vitamin K and vitamin… | 5 mg | 13531-5 | More Info |
| (+)-Warfarin | An anticoagulant; interferes with interconversion of vitamin K and vitamin… | 1 mg | 13526-1 | More Info |
| (+)-Warfarin | An anticoagulant; interferes with interconversion of vitamin K and vitamin… | 10 mg | 13526-10 | More Info |
| (+)-Warfarin | An anticoagulant; interferes with interconversion of vitamin K and vitamin… | 25 mg | 13526-25 | More Info |
| (+)-Warfarin | An anticoagulant; interferes with interconversion of vitamin K and vitamin… | 5 mg | 13526-5 | More Info |
| WaTx (36-68) (scorpion) (trifluoroacetate salt) | A cell-penetrating peptide and TRPA1 activator; selectively induces curren… | 1 mg | 37495-1 | More Info |
| WaTx (36-68) (scorpion) (trifluoroacetate salt) | A cell-penetrating peptide and TRPA1 activator; selectively induces curren… | 10 mg | 37495-10 | More Info |
| WaTx (36-68) (scorpion) (trifluoroacetate salt) | A cell-penetrating peptide and TRPA1 activator; selectively induces curren… | 5 mg | 37495-5 | More Info |
| WAY-161503 | A full agonist of 5-HT2C receptors (Ki = 3.3 nM) that is ~6-fold less pote… | 1 mg | 17269-1 | More Info |
| WAY-161503 | A full agonist of 5-HT2C receptors (Ki = 3.3 nM) that is ~6-fold less pote… | 10 mg | 17269-10 | More Info |
| WAY-161503 | A full agonist of 5-HT2C receptors (Ki = 3.3 nM) that is ~6-fold less pote… | 5 mg | 17269-5 | More Info |
| WAY-161503 | A full agonist of 5-HT2C receptors (Ki = 3.3 nM) that is ~6-fold less pote… | 50 mg | 17269-50 | More Info |
| WAY-169916 | A pathway-selective estrogen receptor ligand; binds to human ERα and… | 10 mg | 35842-10 | More Info |
| WAY-169916 | A pathway-selective estrogen receptor ligand; binds to human ERα and… | 25 mg | 35842-25 | More Info |
| WAY-169916 | A pathway-selective estrogen receptor ligand; binds to human ERα and… | 5 mg | 35842-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile